Alabi A, Kokou K, Mahmoudou S, Kavishna R, et al. Replication, safety and immunogenicity of the vectored Ebola vaccine rVSV-DeltaG-ZEBOV-GP in a sub-Saharan African paediatric population: a randomised controlled, open-label trial in children aged 1-12 years living in Lambarene, Gabon. J Infect 2024 Aug 7:106237. doi: 10.1016/j.jinf.2024.106237.
PMID: 39121969